1378. Evaluation of the In vitro Activity of Meropenem-Vaborbactam Against Carbapenem-Resistant Enterobacteriaceae, Including Isolates Resistant to Ceftazidime–Avibactam

BACKGROUND: Meropenem-vaborbactam (M-V) is a novel antibiotic for treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections. Our objective was to determine the in vitro activity of meropenem-vaborbactam against genetically-diverse CRE isolates, including those that have developed resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, William R, Kline, Ellen, Jones, Chelsea, Morder, Kristin, Clancy, Cornelius J, Nguyen, M Hong, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252943/
http://dx.doi.org/10.1093/ofid/ofy210.1209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252943/
http://dx.doi.org/10.1093/ofid/ofy210.1209

Ejemplares similares